Exacerbations of chronic obstructive pulmonary disease: Time to rename

Exacerbations of chronic obstructive pulmonary disease: Time to rename

In medicine, our terminology becomes fixed, with repercussions when translated between languages, discussed among health-care professionals, and converted into lay terms for patients. For example, for chronic obstructive pulmonary disease, in using COPD as an abbreviation, the letters C, O, P, and D...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Bafadhel, M, Criner, G, Dransfield, M, Janssens, W, McDonald, V, Vogelmeier, C, Russell, R
Kolejni autorzy:	Collis, P
Format:	Journal article
Język:	English
Wydane:	Elsevier 2019

Podobne zapisy

Renaming COPD exacerbations: the UK respiratory nursing perspective
od: Christine Mwasuku, i wsp.
Wydane: (2021-09-01)

Chronic obstructive pulmonary disease – management of chronic disease
od: Ramakrishnan, S, i wsp.
Wydane: (2020)

Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
od: Singh D, i wsp.
Wydane: (2023-07-01)

Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission.
od: Dransfield, M, i wsp.
Wydane: (2019)

Chronic obstructive pulmonary disease: Management of chronic disease
od: Russell, R, i wsp.
Wydane: (2012)

Chronic obstructive pulmonary disease: management of chronic disease
od: Bafadhel, M, i wsp.
Wydane: (2016)

Chronic obstructive pulmonary disease: Management of chronic disease
od: Hambleton, K, i wsp.
Wydane: (2016)

Self-reported sleep quality and acute exacerbations of chronic obstructive pulmonary disease
od: Geiger-Brown J, i wsp.
Wydane: (2015-02-01)

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
od: Mark T. Dransfield, i wsp.
Wydane: (2022-09-01)

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
od: Bafadhel, M, i wsp.
Wydane: (2011)

Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations
od: Wei Xiao, i wsp.
Wydane: (2024-04-01)

THERAPY FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
od: A. A. Zaitsev
Wydane: (2017-12-01)

Treatment of exacerbations of chronic obstructive pulmonary disease
od: S N Avdeev, i wsp.
Wydane: (2018-12-01)

Book review: Chronic Obstructive Pulmonary Disease Exacerbations
od: M. Gaga
Wydane: (2009-12-01)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
od: Mkorombindo T, i wsp.
Wydane: (2019-08-01)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
od: Sean Duffy, i wsp.
Wydane: (2017-06-01)

Pulmonary embolus and acute exacerbations of chronic obstructive pulmonary disease
od: Hawa Edriss, i wsp.
Wydane: (2014-10-01)

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
od: Milo Puhan, i wsp.

Renaming non-communicable diseases
od: Guanyang Zou, i wsp.
Wydane: (2017-07-01)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
od: Bafadhel, M, i wsp.
Wydane: (2012)

PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
od: S. N. Avdeev
Wydane: (2019-05-01)

Rates and Patterns of Chronic Obstructive Pulmonary Disease Exacerbations
od: Magda Nunes de Melo, i wsp.
Wydane: (2004-01-01)

The Nutritional Status of Chronic Obstructive Pulmonary Disease Exacerbators
od: Carina Rôlo Silvestre, i wsp.
Wydane: (2022-01-01)

Managment acute exacerbation of chronic obstructive pulmonary disease
od: Pavlović Tanja, i wsp.
Wydane: (2018-01-01)

[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
od: Domenico Lorenzo Urso
Wydane: (2017-07-01)

Chronic obstructive pulmonary disease exacerbation frequency and severity
od: Stafyla E, i wsp.
Wydane: (2013-11-01)

Markers of exacerbation severity in chronic obstructive pulmonary disease
od: Walker Michael J, i wsp.
Wydane: (2006-05-01)

Prognostic factors in exacerbated chronic obstructive pulmonary disease
od: Iraibis Rodríguez-Pérez, i wsp.
Wydane: (2021-03-01)

NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease
od: Claus Vogelmeier, i wsp.
Wydane: (2011-06-01)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
od: Bafadhel, M, i wsp.
Wydane: (2018)

Renaming the NCDs
od: Arjuna Aluwihare
Wydane: (2002-01-01)

The Politics of Renaming
od: Kari Palonen
Wydane: (2004-01-01)

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
od: Ana I. Hernández Cordero, i wsp.
Wydane: (2021-12-01)

Frailty and Exacerbation of Chronic Obstructive Pulmonary Disease: Is There Any Association?
od: Nishimura K, i wsp.
Wydane: (2024-05-01)

Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
od: Bafadhel, M, i wsp.
Wydane: (2018)

New Perspectives on Chronic Obstructive Pulmonary Disease
od: Celli BR, i wsp.
Wydane: (2022-09-01)

Antimicrobials in Acute Exacerbations of Chronic Obstructive Pulmonary Disease - An Analysis of the Time to Next Exacerbation Before and After Implementation of Standing Orders
od: Rob D Goddard, i wsp.
Wydane: (2003-01-01)

Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease
od: Gulcev M, i wsp.
Wydane: (2016-09-01)

The respiratory virome and exacerbations in patients with chronic obstructive pulmonary disease.
od: Anneloes L van Rijn, i wsp.
Wydane: (2019-01-01)

The influence of pulmonary rehabilitation on the exacerbations of chronic obstructive pulmonary disease in Serbia
od: Ilić Miroslav, i wsp.
Wydane: (2020-01-01)